[go: up one dir, main page]

GB9704977D0 - FIV vaccine - Google Patents

FIV vaccine

Info

Publication number
GB9704977D0
GB9704977D0 GBGB9704977.9A GB9704977A GB9704977D0 GB 9704977 D0 GB9704977 D0 GB 9704977D0 GB 9704977 A GB9704977 A GB 9704977A GB 9704977 D0 GB9704977 D0 GB 9704977D0
Authority
GB
United Kingdom
Prior art keywords
fiv vaccine
fiv
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9704977.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Original Assignee
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow filed Critical University of Glasgow
Priority to GBGB9704977.9A priority Critical patent/GB9704977D0/en
Publication of GB9704977D0 publication Critical patent/GB9704977D0/en
Priority to PCT/GB1998/000715 priority patent/WO1998040493A1/en
Priority to AU67369/98A priority patent/AU6736998A/en
Priority to CA002283490A priority patent/CA2283490A1/en
Priority to EP98912585A priority patent/EP1007687A1/en
Priority to JP53935198A priority patent/JP2002501369A/en
Priority to US10/205,534 priority patent/US20030118601A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9704977.9A 1997-03-11 1997-03-11 FIV vaccine Pending GB9704977D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9704977.9A GB9704977D0 (en) 1997-03-11 1997-03-11 FIV vaccine
PCT/GB1998/000715 WO1998040493A1 (en) 1997-03-11 1998-03-10 Fiv vaccine
AU67369/98A AU6736998A (en) 1997-03-11 1998-03-10 Fiv vaccine
CA002283490A CA2283490A1 (en) 1997-03-11 1998-03-10 Fiv vaccine
EP98912585A EP1007687A1 (en) 1997-03-11 1998-03-10 Fiv vaccine
JP53935198A JP2002501369A (en) 1997-03-11 1998-03-10 FIV vaccine
US10/205,534 US20030118601A1 (en) 1997-03-11 2002-07-25 FIV vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704977.9A GB9704977D0 (en) 1997-03-11 1997-03-11 FIV vaccine

Publications (1)

Publication Number Publication Date
GB9704977D0 true GB9704977D0 (en) 1997-04-30

Family

ID=10809020

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9704977.9A Pending GB9704977D0 (en) 1997-03-11 1997-03-11 FIV vaccine

Country Status (6)

Country Link
EP (1) EP1007687A1 (en)
JP (1) JP2002501369A (en)
AU (1) AU6736998A (en)
CA (1) CA2283490A1 (en)
GB (1) GB9704977D0 (en)
WO (1) WO1998040493A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508338A (en) * 1997-12-12 2002-03-19 ナルディニ，ルイジ Therapeutic use of lentiviral vectors
ES2252918T3 (en) * 1998-08-24 2006-05-16 Pfizer Products Inc. CEPA FIV-141 OF THE FELINE IMMUNODEFICIENCY VIRUS AND ITS USES.
US6764676B1 (en) 1998-08-24 2004-07-20 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus
EP1074625A3 (en) 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus
US8473414B2 (en) * 2010-04-09 2013-06-25 Visa International Service Association System and method including chip-based device processing for transaction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
JP2000506727A (en) * 1996-03-05 2000-06-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Recombinant live cat immunodeficiency virus and proviral DNA vaccine

Also Published As

Publication number Publication date
JP2002501369A (en) 2002-01-15
CA2283490A1 (en) 1998-09-17
WO1998040493A1 (en) 1998-09-17
AU6736998A (en) 1998-09-29
EP1007687A1 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
IL136447A0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
GB9812613D0 (en) Vaccine
ZA9711565B (en) Vaccine
GB0027072D0 (en) Vaccine
GB9704977D0 (en) FIV vaccine
ZA982763B (en) Vaccines
GB9625968D0 (en) Vaccine
GB9718616D0 (en) Oral vaccine
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine
GB9820956D0 (en) Vaccine
GB9807805D0 (en) Vaccine
GB9703202D0 (en) HIV vaccine
GB9725241D0 (en) Hiv vaccine
GB9702920D0 (en) Vaccines
GB9625966D0 (en) Vaccine
GB9625967D0 (en) Vaccine
GB9722097D0 (en) Easy stack
GB9806765D0 (en) Vaccine